Youth gender care evidence

The article directly attacks evidentiary claims behind pediatric gender treatments, arguing that GRADE/EBM are being misapplied to justify care amid low-quality evidence and that Guyatt’s deference to autonomy undermines proper standards—precisely the ongoing conflict over evidence thresholds and guidance.

The piece contends leading proponents have hidden or refused to publish data and made misleading claims, suggesting congressional subpoenas or regulation may be warranted—directly engaging the ongoing fight over evidentiary standards, transparency, and federal/state guidance for pediatric gender treatments.

The article argues experts misrepresented the HHS report and invoked professional consensus, spotlighting disputes over what counts as valid evidence.

The article centers on SCOTUS upholding Tennessee’s ban on puberty blockers and hormones for minors, escalating conflict over evidence standards and federal guidance for pediatric gender treatments by empowering states to legislate despite contested medical claims.